In a citizen petition to the FDA, Valisure said Zantac's originator, Glaxo Research Group, conducted its own study in 1987 "after numerous studies raised concerns" about ranitidine.

The FDA has requested all ranitidine (Zantac) products be pulled from the market immediately. The recall includes all prescription and over-the-counter ranitidine drugs as ongoing investigations ...

Valisure says the FDA should recall Sanofi’s Zantac and all other ranitidine products “to protect the American public from further exposure to the potentially carcinogenic properties of ...

FDA calls for heartburn drug Zantac to be pulled from market immediately ... the company said it issued the recall “due to inconsistencies in preliminary test results.” Ad Feedback.

A probable carcinogen that prompted the recall of several versions of blood pressure-lowering pills has been detected in the heartburn drug Zantac and its generic versions, the Food and Drug ...

The FDA is also advising consumers taking OTC ranitidine to stop taking any tablets or liquid they currently have, dispose of them properly and not buy more. Don't Edit American Health Packaging ...

The move marks the first time the FDA has suggested drug makers should recall the ranitidine heartburn pills since opening a probe several weeks ago. Skip to Main Content RFK Jr.

A CVS Pharmacy drug store in Washington, DC. CVS has recalled Zantac following an investigation launched by the FDA examining its link to cancer.

This week’s recalls are a new cause for alarm for the 15 million Americans who take ranitidine at prescription levels, and the millions more who regularly take lower-dose, over-the-counter versions.

Update 8:55 a.m. EST, Nov 13: The Food and Drug Administration is telling patients and health professionals about two more voluntary recalls of ranitidine. Amneal Pharmaceuticals LLC has recalled ...

Amidst recalls over the popular heartburn OTC medication Zantac over suspected carcinogens, the FDA has released a list of safe antacid alternatives.